Author:
S�rensen Bente T.,Str�mgren Annette,Jakobsen Preben,Jakobsen Anders
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference22 articles.
1. Alberts D, Green S, Hannigan E, O'Toole R, Mason-Liddil N, Surwit E, Stock-Novack D, Goldberg R, Malviya V, Nahhas W (1989) Improved efficacy of carboplatin (CarboP)/cyclophosphamide (CPA) vs cisplatin (CisP)/CPA: preliminary report of a phase III, randomized trial in stages III?IV, suboptimal ovarian cancer (OV CA). Proc Am Soc Clin Oncol 8: 588
2. Belani CP, Egorin MJ (1990) Reply to letter. J Clin Oncol 8: 1284?1285
3. Belani CP, Egorin MJ, Abrams JS, Hiponia D, Eisenberger M, Aisner J, Van Echo DA (1989) A novel pharmacodynamically based approach to dose optimization of carboplatin when used in combination with etoposide. J Clin Oncol 7: 1896?1902
4. Brøchner-Mortensen J (1972) A simple method for determination of glomerular filtration rate. Scand J Clin Lab Invest 30: 271
5. Calvert AH, Harland SJ, Newell DR, Siddik ZH, Jones AC, McElwain TJ, Raju S, Wiltshaw E, Smith IE, Baker JM, Peckham MJ, Harrap KR (1982) Early clinical studies withcis-diammine-1,1-cyclobutane dicarboxylate platinum (II). Cancer Chemother Pharmacol 9: 140
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献